These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications. Zdychová J; Komers R Physiol Res; 2005; 54(1):1-16. PubMed ID: 15717836 [TBL] [Abstract][Full Text] [Related]
5. Expatiating the molecular approaches of HMGB1 in diabetes mellitus: Highlighting signalling pathways via RAGE and TLRs. Behl T; Sharma E; Sehgal A; Kaur I; Kumar A; Arora R; Pal G; Kakkar M; Kumar R; Bungau S Mol Biol Rep; 2021 Feb; 48(2):1869-1881. PubMed ID: 33479829 [TBL] [Abstract][Full Text] [Related]
6. The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis. Hovland A; Jonasson L; Garred P; Yndestad A; Aukrust P; Lappegård KT; Espevik T; Mollnes TE Atherosclerosis; 2015 Aug; 241(2):480-94. PubMed ID: 26086357 [TBL] [Abstract][Full Text] [Related]
7. The influence of Flightless I on Toll-like-receptor-mediated inflammation in a murine model of diabetic wound healing. Ruzehaji N; Mills SJ; Melville E; Arkell R; Fitridge R; Cowin AJ Biomed Res Int; 2013; 2013():389792. PubMed ID: 23555084 [TBL] [Abstract][Full Text] [Related]
8. Global cardiovascular disease risk assessment in United States adults with diabetes. Wong ND; Glovaci D; Wong K; Malik S; Franklin SS; Wygant G; Iloeje U Diab Vasc Dis Res; 2012 Apr; 9(2):146-52. PubMed ID: 22377485 [TBL] [Abstract][Full Text] [Related]
9. Role of inflammatory cells and toll-like receptors in atherosclerosis. Seneviratne AN; Monaco C Curr Vasc Pharmacol; 2015; 13(2):146-60. PubMed ID: 24188491 [TBL] [Abstract][Full Text] [Related]
13. Nrf2 Signaling Pathway as a Key to Treatment for Diabetic Dyslipidemia and Atherosclerosis. Yi M; Toribio AJ; Salem YM; Alexander M; Ferrey A; Swentek L; Tantisattamo E; Ichii H Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892018 [TBL] [Abstract][Full Text] [Related]
14. Innate immune receptors in type 1 diabetes: the relationship to cell death-associated inflammation. Kim TK; Lee MS Biochem Soc Trans; 2020 Jun; 48(3):1213-1225. PubMed ID: 32510139 [TBL] [Abstract][Full Text] [Related]
15. Role of ceramides in the pathogenesis of diabetes mellitus and its complications. Mandal N; Grambergs R; Mondal K; Basu SK; Tahia F; Dagogo-Jack S J Diabetes Complications; 2021 Feb; 35(2):107734. PubMed ID: 33268241 [TBL] [Abstract][Full Text] [Related]
16. Research Progress of Mechanisms and Drug Therapy For Atherosclerosis on Toll-Like Receptor Pathway. Yin QY; Zhao B; Qiu YY; Fei YX; Hu YH; Li YM J Cardiovasc Pharmacol; 2019 Nov; 74(5):379-388. PubMed ID: 31730559 [TBL] [Abstract][Full Text] [Related]
17. The long-term management of pancreas transplantation. Mai ML; Ahsan N; Gonwa T Transplantation; 2006 Oct; 82(8):991-1003. PubMed ID: 17060846 [TBL] [Abstract][Full Text] [Related]
18. Toll-like receptors and type 1 diabetes. Zipris D Adv Exp Med Biol; 2010; 654():585-610. PubMed ID: 20217515 [TBL] [Abstract][Full Text] [Related]
19. Toll-like receptors, their ligands, and atherosclerosis. Hodgkinson CP; Ye S ScientificWorldJournal; 2011 Feb; 11():437-53. PubMed ID: 21336459 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular disease in type 1 diabetes: A review of epidemiological data and underlying mechanisms. Vergès B Diabetes Metab; 2020 Nov; 46(6):442-449. PubMed ID: 32998054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]